Macrophage function in atherosclerosis: Potential roles of TRP channels

Channels

Volumn 6, Issue 3, 2012, Pages 141-148

  Tano, Jean Yves K ^a   Lee, Robert H ^a   Vazquez, Guillermo ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; Efferocytosis; Macrophage apoptosis; Macrophage survival; TRP channels

Indexed keywords

TRANSIENT RECEPTOR POTENTIAL CHANNEL;

ATHEROSCLEROSIS; CELL FUNCTION; HUMAN; MACROPHAGE; MONOCYTE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW;

EID: 84864415271     PISSN: 19336950     EISSN: 19336969     Source Type: Journal    
DOI: 10.4161/chan.20292     Document Type: Review

References (59)

1. Association AH. Heart Disease and Stroke Statistics. Update, Dallas TX, AHA 2008.
2. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 2010; 10:36-46; PMID:19960040; http://dx.doi.org/10.1038/nri2675.
3. Smedlund K, Tano JY, Vazquez G. The constitutive function of native TRPC3 channels modulates vascular cell adhesion molecule-1 expression in coronary endothelial cells through nuclear factorkappaB signaling. Circ Res 2010; 106:1479-88; PMID:20360250; http://dx.doi.org/10.1161/CIRCRESAHA.109.213314.
4. Smedlund K, Vazquez G. Involvement of native TRPC3 proteins in ATP-dependent expression of VCAM-1 and monocyte adherence in coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 2008; 28:2049-55; PMID:18787184; http://dx.doi.org/10.1161/ATVBAHA.108.175356.
5. Tano JY, Smedlund K, Lee R, Abramowitz J, Birnbaumer L, Vazquez G. Impairment of survival signaling and efferocytosis in TRPC3-deficient macrophages. Biochem Biophys Res Commun 2011; 410:643-7; PMID:21684255; http://dx.doi.org/10.1016/j.bbrc.2011.06.045.
6. Montell C, Birnbaumer L, Flockerzi V. The TRP channels, a remarkably functional family. Cell 2002; 108:595-8; PMID:11893331; http://dx.doi.org/10. 1016/S0092-8674(02)00670-0.
7. Vazquez G, Wedel BJ, Aziz O, Trebak M, Putney JW Jr. The mammalian TRPC cation channels. Biochim Biophys Acta 2004; 1742:21-36; PMID:15590053; http://dx.doi.org/10.1016/j.bbamcr.2004.08.015.
8. Nilius B, Owsianik G. The transient receptor potential family of ion channels. Genome Biol 2011; 12:218; PMID:21401968; http://dx.doi.org/10.1186/gb- 2011-12-3-218.
9. Abramowitz J, Birnbaumer L. Physiology and pathophysiology of canonical transient receptor potential channels. FASEB J 2009; 23:297-328; PMID:18940894; http://dx.doi.org/10.1096/fj.08-119495.
10. Trebak M, Vazquez G, Bird GS, Putney JW Jr. The TRPC3/6/7 subfamily of cation channels. Cell Calcium 2003; 33:451-61; PMID:12765690; http://dx.doi.org/10.1016/S0143-4160(03)00056-3.
11. Tano JY, Smedlund K, Vazquez G. Endothelial TRPC3/6/7 proteins at the edge of cardiovascular disease. Cardiovasc Hematol Agents Med Chem 2010; 8:76-86; PMID:20214601; http://dx.doi.org/10.2174/187152510790796138.
12. Smyth JT, Dehaven WI, Jones BF, Mercer JC, Trebak M, Vazquez G, et al. Emerging perspectives in store-operated Ca2+ entry: roles of Orai, Stim and TRP. Biochim Biophys Acta 2006; 1763:1147-60; PMID:17034882; http://dx.doi.org/10. 1016/j.bbamcr.2006.08.050.
13. Vazquez G. TRPC channels as prospective targets in atherosclerosis: terra incognita. Front Biosci (Schol Ed) 2012; 4:157-66; PMID:22202050; http://dx.doi.org/10.2741/258.
14. Soehnlein O. Multiple roles for neutrophils in atherosclerosis. Circ Res 2012; 110:875-88; PMID:22427325; http://dx.doi.org/10.1161/CIRCRESAHA.111. 257535.
15. Thorp E, Subramanian M, Tabas I. The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis. Eur J Immunol 2011; 41:2515-8; PMID:21952808; http://dx.doi.org/10.1002/eji.201141719.
16. Oh J, Riek AE, Weng S, Petty M, Kim D, Colonna M, et al. Endoplasmic reticulum stress controls m2 macrophage differentiation and foam cell formation. J Biol Chem 2012; 287:11629-41; PMID:22356914; http://dx.doi.org/10.1074/jbc. M111.338673.
17. McLaren JE, Michael DR, Ashlin TG, Ramji DP. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy. Prog Lipid Res 2011; 50:331-47; PMID:21601592; http://dx.doi.org/10.1016/j.plipres. 2011.04.002.
18. Liu J, Thewke DP, Su YR, Linton MF, Fazio S, Sinensky MS. Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice. Arterioscler Thromb Vasc Biol 2005; 25:174-9; PMID:15499039.
19. Arai S, Shelton JM, Chen M, Bradley MN, Castrillo A, Bookout AL, et al. A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell Metab 2005; 1:201-13; PMID:16054063; http://dx.doi.org/10. 1016/j.cmet.2005.02.002.
20. Babaev VR, Chew JD, Ding L, Davis S, Breyer MD, Breyer RM, et al. Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis. Cell Metab 2008; 8:492-501; PMID:19041765; http://dx.doi.org/ 10.1016/j.cmet.2008.09.005.
21. Thorp E, Cui D, Schrijvers DM, Kuriakose G, Tabas I. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice. Arterioscler Thromb Vasc Biol 2008; 28:1421-8; PMID:18451332; http://dx.doi.org/10.1161/ATVBAHA.108.167197.
22. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, et al. A definition of initial, fatty streak and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb 1994; 14:840-56; PMID:8172861; http://dx.doi.org/10.1161/01.ATV.14.5.840.
23. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995; 15:1512-31; PMID:7670967; http://dx.doi.org/10.1161/01.ATV.15.9.1512.
24. Tabas I. The role of endoplasmic reticulum stress in the progression of atherosclerosis. Circ Res 2010; 107:839-50; PMID:20884885; http://dx.doi.org/10. 1161/CIRCRESAHA.110.224766.
25. Szegezdi E, Logue SE, Gorman AM, Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 2006; 7:880-5; PMID:16953201; http://dx.doi.org/10.1038/sj.embor.7400779.
26. Gautier EL, Huby T, Witztum JL, Ouzilleau B, Miller ER, Saint-Charles F, et al. Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage. Circulation 2009; 119:1795-804; PMID:19307478; http://dx.doi.org/10.1161/CIRCULATIONAHA.108.806158.
27. Seimon TA, Wang Y, Han S, Senokuchi T, Schrijvers DM, Kuriakose G, et al. Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. J Clin Invest 2009; 119:886-98; PMID:19287091.
28. Lim WS, Timmins JM, Seimon TA, Sadler A, Kolodgie FD, Virmani R, et al. Signal transducer and activator of transcription-1 is critical for apoptosis in macrophages subjected to endoplasmic reticulum stress in vitro and in advanced atherosclerotic lesions in vivo. Circulation 2008; 117:940-51; PMID:18227389; http://dx.doi.org/10.1161/CIRCULATIONAHA.107.711275.
29. Berthier A, Lemaire-Ewing S, Prunet C, Monier S, Athias A, Bessède G, et al. Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-keto-cholesterol-induced THP-1 cell apoptosis. Cell Death Differ 2004; 11:897-905; PMID:15105836; http://dx.doi.org/10.1038/sj.cdd.4401434.
30. Ley K, Miller YI, Hedrick CC. Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol 2011; 31:1506-16; PMID:21677293; http://dx.doi.org/10.1161/ATVBAHA.110.221127.
31. Liu D, Scholze A, Zhu Z, Kreutz R, Wehland-von-Trebra M, Zidek W, et al. Increased transient receptor potential channel TRPC3 expression in spontaneously hypertensive rats. Am J Hypertens 2005; 18:1503-7; PMID:16280289; http://dx.doi.org/10.1016/j.amjhyper.2005.05.033.
32. Liu DY, Scholze A, Kreutz R, Wehland-von-Trebra M, Zidek W, Zhu ZM, et al. Monocytes from spontaneously hypertensive rats show increased store-operated and second messenger-operated calcium influx mediated by transient receptor potential canonical Type 3 channels. Am J Hypertens 2007; 20:1111-8; PMID:17903696; http://dx.doi.org/10.1016/j.amjhyper.2007.04.004.
33. Liu D, Scholze A, Zhu Z, Krueger K, Thilo F, Burkert A, et al. Transient receptor potential channels in essential hypertension. J Hypertens 2006; 24:1105-14; PMID:16685211; http://dx.doi.org/10.1097/01.hjh.0000226201.73065.14.
34. Liu DY, Thilo F, Scholze A, Wittstock A, Zhao ZG, Harteneck C, et al. Increased store-operated and 1-oleoyl-2-acetyl-sn-glycerol-induced calcium influx in monocytes is mediated by transient receptor potential canonical channels in human essential hypertension. J Hypertens 2007; 25:799-808; PMID:17351372; http://dx.doi.org/10.1097/HJH.0b013e32803cae2b.
35. Zhao Z, Ni Y, Chen J, Zhong J, Yu H, Xu X, et al. Increased migration of monocytes in essential hypertension is associated with increased transient receptor potential channel canonical type 3 channels. PLoS One 2012; 7:32628; PMID:22438881; http://dx.doi.org/10.1371/journal.pone.0032628.
36. Liu Y, Xu Y, Thilo F, Friis UG, Jensen BL, Scholze A, et al. Erythropoietin increases expression and function of transient receptor potential canonical 5 channels. Hypertension 2011; 58:317-24; PMID:21690481; http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.173690.
37. Thilo F, Scholze A, Liu DY, Zidek W, Tepel M. Association of transient receptor potential canonical type 3 (TRPC3) channel transcripts with proinflammatory cytokines. Arch Biochem Biophys 2008; 471:57-62; PMID:18177730; http://dx.doi.org/10.1016/j.abb.2007.12.006.
38. Wuensch T, Thilo F, Krueger K, Scholze A, Ristow M, Tepel M. High glucose-induced oxidative stress increases transient receptor potential channel expression in human monocytes. Diabetes 2010; 59:844-9; PMID:20068131; http://dx.doi.org/10.2337/db09-1100.
39. Finney-Hayward TK, Popa MO, Bahra P, Li S, Poll CT, Gosling M, et al. Expression of transient receptor potential C6 channels in human lung macrophages. Am J Respir Cell Mol Biol 2010; 43:296-304; PMID:19843708; http://dx.doi.org/10.1165/rcmb.2008-0373OC.
40. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 1999; 13:2905-27; PMID:10579998; http://dx.doi.org/10.1101/gad. 13.22.2905.
41. Deguchi JO, Yamazaki H, Aikawa E, Aikawa M. Chronic hypoxia activates the Akt and β-catenin pathways in human macrophages. Arterioscler Thromb Vasc Biol 2009; 29:1664-70; PMID:19644051; http://dx.doi.org/10.1161/ATVBAHA.109. 194043.
42. Bai D, Ueno L, Vogt PK. Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt. Int J Cancer 2009; 125:2863-70; PMID:19609947; http://dx.doi.org/10.1002/ijc.24748.
43. Madrid LV, Wang CY, Guttridge DC, Schottelius AJG, Baldwin AS Jr, Mayo MW. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NFkappaB. Mol Cell Biol 2000; 20:1626-38; PMID:10669740; http://dx.doi.org/10.1128/MCB.20.5.1626-38.2000.
44. Romashkova JA, Makarov SS. NFkappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999; 401:86-90; PMID:10485711; http://dx.doi.org/10. 1038/43474.
45. Tano JY, Vazquez G. Requirement for non-regulated, constitutive calcium influx in macrophage survival signaling. Biochem Biophys Res Commun 2011; 407:432-7; PMID:21414290; http://dx.doi.org/10.1016/j.bbrc.2011.03.048.
46. Ambudkar IS, Ong HL. Organization and function of TRPC channelosomes. Pflugers Arch 2007; 455:187-200; http://dx.doi.org/10.1007/s00424-007-0252-0.
47. Timmins JM, Ozcan L, Seimon TA, Li G, Malagelada C, Backs J, et al. Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways. J Clin Invest 2009; 119:2925-41; PMID:19741297; http://dx.doi.org/10.1172/JCI38857.
48. Nagasawa M, Nakagawa Y, Tanaka S, Kojima I. Chemotactic peptide fMetLeuPhe induces translocation of the TRPV2 channel in macrophages. J Cell Physiol 2007; 210:692-702; PMID:17154364; http://dx.doi.org/10.1002/jcp.20883.
49. Nagasawa M, Kojima I. Translocation of calcium-permeable TRPV2 channel to the podosome: Its role in the regulation of podosome assembly. Cell Calcium 2012; 51:186-93; PMID:22226146; http://dx.doi.org/10.1016/j.ceca.2011.12.012.
50. Link TM, Park U, Vonakis BM, Raben DM, Soloski MJ, Caterina MJ. TRPV2 has a pivotal role in macrophage particle binding and phagocytosis. Nat Immunol 2010; 11:232-9; PMID:20118928; http://dx.doi.org/10.1038/ni.1842.
51. Buczynski MW, Stephens DL, Bowers-Gentry RC, Grkovich A, Deems RA, Dennis EA. TLR-4 and sustained calcium agonists synergistically produce eicosanoids independent of protein synthesis in RAW264.7 cells. J Biol Chem 2007; 282:22834-47; PMID:17535806; http://dx.doi.org/10.1074/jbc.M701831200.
52. Seimon TA, Obstfeld A, Moore KJ, Golenbock DT, Tabas I. Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages. Proc Natl Acad Sci USA 2006; 103:19794-9; PMID:17167049; http://dx.doi.org/10.1073/pnas.0609671104.
53. Yamashiro K, Sasano T, Tojo K, Namekata I, Kurokawa J, Sawada N, et al. Role of transient receptor potential vanilloid 2 in LPS-induced cytokine production in macrophages. Biochem Biophys Res Commun 2010; 398:284-9; PMID:20599720; http://dx.doi.org/10.1016/j.bbrc.2010.06.082.
54. Schilling T, Eder C. Non-selective cation channel activity is required for lysophosphatidylcholine-induced monocyte migration. J Cell Physiol 2009; 221:325-34; PMID:19562685; http://dx.doi.org/10.1002/jcp.21857.
55. Yamamoto S, Shimizu S, Kiyonaka S, Takahashi N, Wajima T, Hara Y, et al. TRPM2-mediated Ca2+ influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat Med 2008; 14:738-47; PMID:18542050; http://dx.doi.org/10.1038/nm1758.
56. Knowles H, Heizer JW, Li Y, Chapman K, Ogden CA, Andreasen K, et al. Transient Receptor Potential Melastatin 2 (TRPM2) ion channel is required for innate immunity against Listeria monocytogenes. Proceedings of the National Academy of Sciences 108:11578-83.
57. Takahashi N, Kozai D, Kobayashi R, Ebert M, Mori Y. Roles of TRPM2 in oxidative stress. Cell Calcium 2011; 50:279-87; PMID:21616534; http://dx.doi.org/10.1016/j.ceca.2011.04.006.
58. Wehrhahn J, Kraft R, Harteneck C, Hauschildt S. Transient receptor potential melastatin 2 is required for lipopolysaccharide-induced cytokine production in human monocytes. J Immunol 2010; 184:2386-93; PMID:20107186; http://dx.doi.org/10.4049/jimmunol.0902474.
59. Wu SN, Wu PY, Tsai ML. Characterization of TRPM8-like channels activated by the cooling agent icilin in the macrophage cell line RAW 264.7. J Membr Biol 2011; 241:11-20; PMID:21445583; http://dx.doi.org/10.1007/s00232-011-9358-6.